CCL2 and lung carcinoma: Notably, a significant correlation was found between MALAT1 and MCP-1 levels in the plasma of lung cancer patients from the AA population (r = 0.935, p = 0.001) (Figure 2B), a correlation not observed in the WA population (r = 0.229, p = 0.096) (Figure 2B,C).